User profiles for Peter Rossing
 | Peter RossingSteno Diabetes Center Verified email at dadlnet.dk Cited by 69420 |
[PDF][PDF] Diabetes and hypertension: a position statement by the American Diabetes Association
Hypertension is common among patients with diabetes, with the prevalence depending on
type and duration of diabetes, age, sex, race/ethnicity, BMI, history of glycemic control, and …
type and duration of diabetes, age, sex, race/ethnicity, BMI, history of glycemic control, and …
[HTML][HTML] Cardiovascular events with finerenone in kidney disease and type 2 diabetes
Background Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist,
has favorable effects on cardiorenal outcomes in patients with predominantly stage 3 or 4 …
has favorable effects on cardiorenal outcomes in patients with predominantly stage 3 or 4 …
[HTML][HTML] Dapagliflozin in patients with chronic kidney disease
…, JJV McMurray, M Lindberg, P Rossing… - … England Journal of …, 2020 - Mass Medical Soc
Background Patients with chronic kidney disease have a high risk of adverse kidney and
cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, …
cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, …
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Aims The complementary studies FIDELIO-DKD and FIGARO-DKD in patients with type 2
diabetes and chronic kidney disease (CKD) examined cardiovascular and kidney outcomes in …
diabetes and chronic kidney disease (CKD) examined cardiovascular and kidney outcomes in …
[HTML][HTML] Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
Background Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist,
reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) …
reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) …
Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …
The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the prior position statements, published in 2012 and 2015, on …
convened a panel to update the prior position statements, published in 2012 and 2015, on …
2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European …
The American Diabetes Association and the European Association for the Study of Diabetes
have briefly updated their 2018 recommendations on management of hyperglycemia, …
have briefly updated their 2018 recommendations on management of hyperglycemia, …
[HTML][HTML] New creatinine-and cystatin C–based equations to estimate GFR without race
…, ED Poggio, R Rodby, P Rossing… - … England Journal of …, 2021 - Mass Medical Soc
Background Current equations for estimated glomerular filtration rate (eGFR) that use serum
creatinine or cystatin C incorporate age, sex, and race to estimate measured GFR. However…
creatinine or cystatin C incorporate age, sex, and race to estimate measured GFR. However…
[HTML][HTML] Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for …
The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the prior position statements, published in 2012 and 2015, on …
convened a panel to update the prior position statements, published in 2012 and 2015, on …
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
…, HJL Heerspink, BJ Lee, RM Perkins, P Rossing… - The Lancet, 2012 - thelancet.com
Background Chronic kidney disease is characterised by low estimated glomerular filtration
rate (eGFR) and high albuminuria, and is associated with adverse outcomes. Whether these …
rate (eGFR) and high albuminuria, and is associated with adverse outcomes. Whether these …